Market Research Logo

Autism Spectrum Disorder Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Autism Spectrum Disorder Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Autism, scientifically referred as Autism Spectrum Disorder Therapeutics (ASD) is a complex neurological disorder that is characterized by symptoms including challenges with social skills, repetitive behaviours, as well as issues with speech and non-verbal communication. Major companies operating in the ASD therapeutics market are focusing on extensive research & development and clinical trials to introduce new drugs. For instance, in February 2019, Servier Laboratories Ltd. and Neurochlore announced the launch of phase 3 studies to evaluate the use of Bumetanide in children with ASD. Bumetanide is typically used to treat fluid retention (edema) and high blood pressure.

Market Dynamics

Increasing prevalence of ASD worldwide is expected to boost the Autism Spectrum Disorder Therapeutics (ASD) therapeutics market growth. For instance, according to the data published in Our World in Data in 2017, around 62 million people worldwide were estimated to have ASD in 2016. Moreover, under 50 million of these cases were found in males. Of this 62 million with ASD, around 18 million had only Autism and 44 million had Asperger syndrome and other spectrum disorders.

However, stringent regulations and continuous watch employed by governing authorities for product approval and marketing of medicines can act as a potential hindrance for growth of the autism spectrum disorder therapeutics market. For instance, in May 2017, the U.S. Food and Drug Administration (FDA) shut down operations of Louisiana-based Pick and Pay Inc. / Cili Minerals, a manufacturer of drug and dietary supplements, after finding that the company was falsely marketing products as being able to treat autism.

Key features of the study:

  • This report provides in-depth analysis of the autism spectrum disorder therapeutics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global autism spectrum disorder therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, F. Hoffmann-La Roche AG, Neurim Pharmaceuticals, Inc., Yamo Pharmaceuticals LLC, Servier Laboratories Ltd., Otsuka Holdings Co. Ltd., Curemark LLC, Oryzon Genomics S.A., GW Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Zynerba Pharmaceuticals Inc., Stalicla SA., Novartis AG, Pfizer, Inc., and Bristol Myers Squibb
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global autism spectrum disorder therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Autism Spectrum Disorder Therapeutics market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Autism Spectrum Disorder Therapeutics Market, By Drug Type:
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
  • Global Autism Spectrum Disorder Therapeutics Market, By Age Group:
  • Child
  • Adult
  • Global Autism Spectrum Disorder Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Autism Spectrum Disorder Therapeutics Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Drug Type:
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
  • By Age Group:
  • Child
  • Adult
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Drug Type:
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
  • By Age Group:
  • Child
  • Adult
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Drug Type:
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
  • By Age Group:
  • Child
  • Adult
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Drug Type:
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
  • By Age Group:
  • Child
  • Adult
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Drug Type:
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
  • By Age Group:
  • Child
  • Adult
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • By Drug Type:
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
  • By Age Group:
  • Child
  • Adult
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • F. Hoffmann-La Roche AG.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Neurim Pharmaceuticals, Inc.
  • Yamo Pharmaceuticals LLC
  • Servier Laboratories Ltd.
  • Otsuka Holdings Co. Ltd.
  • Curemark LLC
  • Oryzon Genomics S.A.
  • GW Pharmaceuticals Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Zynerba Pharmaceuticals Inc.
  • Stalicla SA.
  • Novartis AG
  • Pfizer, Inc.
  • Bristol Myers Squibb.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Age Group
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Collaborations & Partnerships
Epidemiology Analysis
Pipeline Analysis & Approved Product Analysis
Regulatory Scenario
Reimbursement Scenario
Porter’s Five Forces model
4. Global Autism Spectrum Disorder Therapeutics Market, By Drug Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Aripiprazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Risperidone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Melatonin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
CM-AT
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Bumetanide
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Balovaptan
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
5. Global Autism Spectrum Disorder Therapeutics Market, By Age Group, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Child
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
6. Global Autism Spectrum Disorder Therapeutics Market, By Distribution Channel, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
7. Global Autism Spectrum Disorder Therapeutics Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Drug Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Age Group, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Age Group, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Age Group, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Age Group, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Age Group, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country/Region, 2018 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drug Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Age Group, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
GCC
Israel
Rest of Middle East
8. Competitive Landscape
Company Profiles
F. Hoffmann-La Roche AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Neurim Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Yamo Pharmaceuticals LLC
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Servier Laboratories Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Otsuka Holdings Co. Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Curemark LLC
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Oryzon Genomics S.A.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
GW Pharmaceuticals Plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Zynerba Pharmaceuticals Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
STALICLA SA
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bristol Myers Squibb
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 38 market data tables and 27 figures on "Autism Spectrum Disorder Therapeutics Market” - Global forecast to 2026”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report